首页> 外国专利> METHOD FOR PRODUCING MESENCHYMAL STEM CELLS, THERAPEUTIC EFFECT MARKER OF MESENCHYMAL STEM CELLS, METHOD FOR DETERMINING THERAPEUTIC EFFECTS OF MESENCHYMAL STEM CELLS, AND CELLULAR PREPARATION CONTAINING MESENCHYMAL STEM CELLS

METHOD FOR PRODUCING MESENCHYMAL STEM CELLS, THERAPEUTIC EFFECT MARKER OF MESENCHYMAL STEM CELLS, METHOD FOR DETERMINING THERAPEUTIC EFFECTS OF MESENCHYMAL STEM CELLS, AND CELLULAR PREPARATION CONTAINING MESENCHYMAL STEM CELLS

机译:制备间充质干细胞的方法,间充质干细胞的治疗作用标记物,测定间充质干细胞的治疗作用的方法以及包含间充质干细胞的细胞制备

摘要

[Problem] To provide a cell preparation including mesenchymal stem cells (MSCs) having a high therapeutic effect. [Solution] A method for producing activated mesenchymal stem cells, including a step of culturing MSCs in a medium containing an activator that includes an extract from a mammalian fetal appendage as an active ingredient, using a cell culture carrier having a three-dimensional structure formed of a fiber is provided. A marker for a therapeutic effect of MSCs selected from the group consisting of p16ink4a, p14ARF, CDK4, CDK6, RB, and CD47, a method for determining a therapeutic effect using the maker, a method for determining suitability of MSCs to be treated with a treatment for enhancing a therapeutic effect of MSCs, a cell preparation including MSCs, and a method for producing the same are also provided.
机译:[问题]提供一种包括具有高治疗效果的间充质干细胞(MSC)的细胞制剂。 [解决方案]一种产生活化的间充质干细胞的方法,包括以下步骤:使用具有形成的三维结构的细胞培养载体,在含有活化剂的培养基中培养MSC,所述活化剂包括来自哺乳动物胎儿附肢的提取物作为活性成分。提供了一根光纤。选自p16ink4a,p14ARF,CDK4,CDK6,RB和CD47的MSC的治疗作用标志物,使用制造商确定治疗作用的方法,确定待用MSC治疗的MSC的适应性的方法还提供了用于增强MSC的治疗效果的治疗方法,包括MSC的细胞制剂及其生产方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号